APA Alıntı

MOTA, T. M., RASMUSSEN, T. A., RHODES, A., TENNAKOON, S., DANTANARAYANA, A., WIGHTMAN, F., . . . LEWIN, S. R. (2017). No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy. AIDS.

Chicago Stili Alıntı

MOTA, Talia M., et al. "No Adverse Safety or Virological Changes Two Years Following Vorinostat in HIV-infected Individuals On Antiretroviral Therapy." AIDS 2017.

MLA Alıntı

MOTA, Talia M., et al. "No Adverse Safety or Virological Changes Two Years Following Vorinostat in HIV-infected Individuals On Antiretroviral Therapy." AIDS 2017.